WWOX Rs11644322 Polymorphism, Gemcitabine, and Pancreatic Cancer
Overview
Overview
Journal
Indian J Med Paediatr Oncol
Publisher
Thieme
Specialty
Oncology
Date
2017 Dec 5
PMID
29200707
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Schirmer M, Luske C, Roppel S, Schaudinn A, Zimmer C, Pfluger R
. Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer. J Natl Cancer Inst. 2016; 108(5).
PMC: 4859408.
DOI: 10.1093/jnci/djv387.
View
2.
Joob B, Wiwanitkit V
. ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: molecular change can explain the observed therapeutic concentration. Anatol J Cardiol. 2016; 16(4):303-4.
PMC: 5368450.
DOI: 10.14744/AnatolJCardiol.2016.7027.
View
3.
Joob B, Wiwanitkit V
. HSD11B1 rs846908 polymorphisms and tacrolimus concentrations: quantum chemical analysis and implication in patients with renal transplantation. J Nephropharmacol. 2017; 6(1):19-20.
PMC: 5295653.
View
4.
Weinberg B, Philip P, Salem M
. Evolving standards of care for resected pancreatic cancer. Clin Adv Hematol Oncol. 2017; 15(2):141-150.
View